B-vitamin Levels and Adverse Pregnancy Outcomes
The Association Between Niacin Deficiency and Birth Defects: a Case-control Study
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100020
- Beijing Obstetrics and Gynecology Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Pregnant women with 6-13(+6 days) gestational weeks
- Resided in Beijing in the past year
- Pregnant women who intend to have antenatal examinations and delivery at Beijing Obstetrics and Gynecology Hospital
- Pregnant women who are willing to participate in this study with informed consent
Exclusion Criteria:
- Women with Hepatitis B, syphilis, HIV/AIDS and other infectious diseases.
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Case group
Case group with certain pregnancy outcome, e.g., miscarriage, stillbirth, preterm birth, and birth defects,gestational hypertension, gestational diabetes mellitus, etc.
|
This is an observational study without any intervention
|
|
Control group
Control group without certain pregnancy outcome,e.g., miscarriage, stillbirth, preterm birth, and birth defects,gestational hypertension, gestational diabetes mellitus, etc.
|
This is an observational study without any intervention
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
fetal outcomes
Time Frame: at delivery
|
Including intrauterine growth retardation,abortion, stillbirth, preterm birth, live birth
|
at delivery
|
|
fetal outcomes
Time Frame: 42 days after delivery
|
Including birth defects
|
42 days after delivery
|
|
maternal outcomes
Time Frame: at delivery
|
Including gestational hypertension, preeclampsia, gestational diabetes mellitus, hypothyroidism
|
at delivery
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Hongjun Shi, PhD, Westlake University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pathologic Processes
- Cardiovascular Diseases
- Vascular Diseases
- Glucose Metabolism Disorders
- Metabolic Diseases
- Endocrine System Diseases
- Diabetes Mellitus
- Obstetric Labor Complications
- Obstetric Labor, Premature
- Death
- Female Urogenital Diseases and Pregnancy Complications
- Urogenital Diseases
- Hypertension
- Congenital Abnormalities
- Premature Birth
- Abortion, Spontaneous
- Pregnancy Complications
- Diabetes, Gestational
- Hypertension, Pregnancy-Induced
- Fetal Death
Other Study ID Numbers
Other Study ID Numbers
- 20210119SHJ001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.